Hudry, E
Martin, C
Gandhi, S
György, B
Scheffer, D I
Mu, D
Merkel, S F
Mingozzi, F
Fitzpatrick, Z
Dimant, H
Masek, M
Ragan, T
Tan, S
Brisson, A R
Ramirez, S H
Hyman, B T
Maguire, C A
Article History
Received: 16 November 2015
Revised: 17 January 2016
Accepted: 19 January 2016
First Online: 2 February 2016
Competing interests
: CM has a patent application related to the Exo-AAV (vexosome) technology and has received royalty payments from agreements between Partners Healthcare and Exosome Diagnostics, Inc. CM has received an honorarium from Biogen Idec for giving a seminar on the technology. The other authors declare no conflict of interest.